Axsome Therapeutics Return On Tangible Equity 2014-2025 | AXSM

Axsome Therapeutics return on tangible equity for the quarter ending March 31, 2025 was -1659.7.

  • Axsome Therapeutics average return on tangible equity for 2024 was -417.8, a 50.26% increase from 2023.
  • Axsome Therapeutics average return on tangible equity for 2023 was -278.06, a 83.61% increase from 2022.
  • Axsome Therapeutics average return on tangible equity for 2022 was -1696.29, a 1085.31% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Axsome Therapeutics Return On Tangible Equity 2014-2025 | AXSM

  • Axsome Therapeutics average return on tangible equity for 2024 was -417.8, a 50.26% increase from 2023.
  • Axsome Therapeutics average return on tangible equity for 2023 was -278.06, a 83.61% increase from 2022.
  • Axsome Therapeutics average return on tangible equity for 2022 was -1696.29, a 1085.31% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.